Global Hepatitis A Vaccine Market Study 2016-2026, by Segment (Liver Inactivated Vaccine, Live Attenuated Vaccine), by Market (Hospitals, Other Medical Institutions), by Company (GlaxoSmithKline, Merck Sharp & Dohme Corp, … …)
SKU ID :99ST-14596610 | Published Date: 12-Oct-2019 | No. of pages: 56Description
Summary
The global Hepatitis A Vaccine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Liver Inactivated Vaccine
Live Attenuated Vaccine
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Other Medical Institutions
GlaxoSmithKline
Merck Sharp & Dohme Corp
SANOFI PASTEUR S.A
Norvatis
Crucell Switzerland AG(Berna+Crucell)
China Academy of Medical Sciences
Changchun Institute of Biological Products
Zhejiang Pukang
ChangSheng
Sinovac
Shanghai Zerun Biotechnology
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Hepatitis A Vaccine market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Liver Inactivated Vaccine
Live Attenuated Vaccine
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospitals
Other Medical Institutions
Company Coverage (Sales data, Main Products & Services etc.):
GlaxoSmithKline
Merck Sharp & Dohme Corp
SANOFI PASTEUR S.A
Norvatis
Crucell Switzerland AG(Berna+Crucell)
China Academy of Medical Sciences
Changchun Institute of Biological Products
Zhejiang Pukang
ChangSheng
Sinovac
Shanghai Zerun Biotechnology
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now